NCT01222767 2021-10-29Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of ChemotherapyPharmaMarPhase 2 Completed17 enrolled 20 charts